Saturday, September 12, 2026

Tiffany Young’s Solo Debut: What to Expect from Edge Of Calm Featuring i-dle’s Miyeon

Tiffany Young's first solo album features support from i-dle's Miyeon, marking an exciting collaboration in the music scene.

Amazon Shares Drop 1% After Weak Revenue Forecast Despite Strong Earnings

Amazon's quarterly earnings surpassed expectations, but a weaker forecast led to a slight dip in stock price after hours.

Wildfire From North Korea Spills Into DMZ, Sparks Two-Day Battle

A wildfire from North Korea has spread to the DMZ in Goseong, prompting ongoing firefighting efforts for a second day.

Tag: ALT-B4

North KoreaKoreaKimMilitaryAISouth Koreamarketrelationsdevelopment

Alteogen Signs Subcutaneous Injection Development Deal With Novartis Worth Up to $3.22 Billion

Alteogen has signed an option and licensing agreement with Novartis to develop and commercialize subcutaneous formulations based on its ALT-B4 technology, with potential payments of up to $3.22 billion plus royalties.

Alteogen and Biogen: A Game-Changing 200 Million USD License Deal for ALT-B4 Biopharmaceuticals

Alteogen partners with Biogen for exclusive licensing of subcutaneous biopharmaceuticals, potentially earning up to 549 million USD.

Alteogen Secures U.S. Patent for Keytruda Subcutaneous Injection: What This Means for ALT-B4 and Future Treatments

Alteogen secures a U.S. patent for a subcutaneous Keytruda formulation using ALT-B4, ensuring exclusivity until 2043 and potential $1B in sales.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.